WR Wealth Planners LLC Cuts Stake in Solventum Co. (NYSE:SOLV)

WR Wealth Planners LLC cut its holdings in Solventum Co. (NYSE:SOLV) by 22.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 907 shares of the company’s stock after selling 267 shares during the quarter. WR Wealth Planners LLC’s holdings in Solventum were worth $60,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Terril Brothers Inc. purchased a new position in Solventum during the fourth quarter worth $5,341,000. SVB Wealth LLC purchased a new position in Solventum during the fourth quarter worth $229,000. Versor Investments LP purchased a new position in Solventum during the fourth quarter worth $263,000. Proficio Capital Partners LLC purchased a new position in Solventum during the fourth quarter worth $1,545,000. Finally, New York Life Investment Management LLC boosted its stake in Solventum by 0.7% during the fourth quarter. New York Life Investment Management LLC now owns 18,506 shares of the company’s stock worth $1,223,000 after buying an additional 136 shares during the period.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Mizuho assumed coverage on shares of Solventum in a research note on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price objective for the company. Bank of America lifted their target price on Solventum from $80.00 to $85.00 and gave the stock a “neutral” rating in a research report on Wednesday. Wells Fargo & Company lifted their target price on Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a research report on Friday. Piper Sandler lifted their target price on Solventum from $75.00 to $84.00 and gave the stock a “neutral” rating in a research report on Friday. Finally, Morgan Stanley lifted their target price on Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. One analyst has rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, Solventum has an average rating of “Hold” and a consensus price target of $74.71.

Solventum Stock Performance

SOLV stock opened at $79.56 on Friday. The company has a market capitalization of $13.74 billion and a P/E ratio of 28.93. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The business has a 50-day moving average price of $72.51 and a 200 day moving average price of $69.96. Solventum Co. has a 1-year low of $47.16 and a 1-year high of $96.05.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.